WallStreetZenWallStreetZen

NASDAQ: TRAX
First Tracks Biotherapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
First Tracks Biotherapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TRAX annual revenue was $0.0, with N/A growth year-over-year.

TRAX revenue history

Current Revenue
$0.0
Current Earnings
-$166.1M
Current Profit Margin
0%

Be the first to know when TRAX announces revenue.

TRAX Revenue History By Year

TRAX Yearly RevenueTRAX RevenueTRAX ChangeTRAX Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A

1 of 1

First Tracks Biotherapeutics Revenue FAQ

What was TRAX's revenue last quarter?

First Tracks Biotherapeutics (NASDAQ: TRAX) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, First Tracks Biotherapeutics's revenue was N/A.

What was First Tracks Biotherapeutics's revenue in 2025?

First Tracks Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does First Tracks Biotherapeutics make in a day?

Based on First Tracks Biotherapeutics annual revenue for the past one years, TRAX makes an average of $0.00 per day.

What was First Tracks Biotherapeutics's annual revenue growth in the past year?

As of Q2 2026, First Tracks Biotherapeutics's revenue has grown null year over year. First Tracks Biotherapeutics's revenue in the past year totaled $0.00.

How much does First Tracks Biotherapeutics make in a year?

First Tracks Biotherapeutics's revenue by year for the past one years is:
  • First Tracks Biotherapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.